Peptidase (DPP-4 Inhibitors)

Also known as: Dipeptidyl Peptidase-4 Inhibitor, DPP-4 Inhibitor, Gliptins, Sitagliptin, Saxagliptin, Alogliptin, Linagliptin

Evidence under review. — Not yet rated

Enzyme-blocking compounds used in diabetes drugs; limited evidence as OTC supplements.

What it does

DPP-4 inhibitors are compounds that block the dipeptidyl peptidase-4 enzyme, which normally breaks down hormones called incretins that help regulate blood sugar after meals. By blocking this...
Evidence quality

Evidence base hasn't been formally rated yet. See research below.
Clinical dose

No established dose for supplement form; prescription drugs dosed at 25-100 mg/day (sitagliptin)

See full breakdown ↓ Methodology →

What the Science Says

DPP-4 inhibitors are compounds that block the dipeptidyl peptidase-4 enzyme, which normally breaks down hormones called incretins that help regulate blood sugar after meals. By blocking this enzyme, more incretin hormones remain active, prompting the pancreas to release more insulin and reducing blood sugar spikes. This mechanism is well-established in prescription diabetes medications (like sitagliptin), but the evidence for over-the-counter supplement forms is extremely limited.

What It Doesn't Do

Not a substitute for prescribed diabetes medication. No solid evidence OTC supplement versions meaningfully lower blood sugar. Won't cause weight loss on its own. Not proven to treat or prevent type 2 diabetes without medical supervision. Don't expect the same results as prescription DPP-4 inhibitor drugs.

Evidence-Based Benefits

Prescription DPP-4 inhibitors significantly lower HbA1c in type 2 diabetes patients when combined with other medications.

Weak Evidence

Effective at: 50 mg/day sitagliptin (prescription only)

Supporting studies (click to view on PubMed):

PMID 24578754

Absorption & Bioavailability

Unknown for supplement forms. Prescription DPP-4 inhibitors (e.g., sitagliptin) have well-characterized oral bioavailability (~87%), but OTC supplement versions have no published absorption data.

Red Flags to Watch For

DPP-4 inhibitors are primarily prescription medications — OTC supplement claims mimicking drug effects should raise serious skepticism.
Taking unregulated DPP-4 inhibitor supplements alongside diabetes medications could cause dangerous blood sugar drops (hypoglycemia).
No regulatory approval exists for DPP-4 inhibitor supplements; products making blood sugar claims may violate FDA guidelines.
Only one small study (26 patients) was available in the provided data — far too little evidence to support broad supplement marketing claims.
People with diabetes should never replace or adjust prescribed medications based on supplement use without consulting a doctor.

Frequently Asked Questions

What does Peptidase (DPP-4 Inhibitors) do?

Enzyme-blocking compounds used in diabetes drugs; limited evidence as OTC supplements.

What is the effective dose of Peptidase (DPP-4 Inhibitors)?

No established dose for supplement form; prescription drugs dosed at 25-100 mg/day (sitagliptin)

Is Peptidase (DPP-4 Inhibitors) safe?

DPP-4 inhibitors are primarily prescription medications — OTC supplement claims mimicking drug effects should raise serious skepticism.

What doesn't Peptidase (DPP-4 Inhibitors) do?

Not a substitute for prescribed diabetes medication.

Research Sources

PMID: 24578754
General knowledge — limited published research available for OTC supplement forms

This information is for educational purposes only and is not medical advice. Always consult a healthcare professional before starting any supplement regimen. Last updated: 2026-05-25